NEW YORK, Feb 5 Johnson & Johnson (J&J) created a plan last year to limit the financial bleeding from billions of dollars in jury awards to plaintiffs who alleged the company’s Baby Powder and other talc products caused deadly cancers. The healthcare and consumer-goods giant assigned.
By Mike Spector and Dan Levine NEW YORK (Reuters) - Johnson & Johnson created a plan last year to limit the financial bleeding from billions of dollar.